PartsTable TECHNICAL DATA SHEET
NSN 6505-01-275-7369Government record, cited

Disopyramide Phosphate Extended-6505-01-275-7369

NSN 6505-01-275-7369 · NIIN 012757369
FSC 6505 — Drugs and Biologicals · FSG 65 — Medical, Dental, and Veterinary Equipment
Government record, cited
Also searched as  6505-01-275-7369 · 6505012757369 · NIIN 012757369 · 01-275-7369 · FSC 6505 Drugs and Biologicals · NORPACE CR · NDC00025-2742-51 · NDC00025-2742-51
Nearby stock numbers  ·
Features
  • Disopyramide Phosphate Extended- — FSC 6505
  • Long Action Method: EXTENDED RELEASE
  • Medical Designation and Grade: UNITED STATES PHARMACOPEIA
  • Primary Container Type: BOTTLE
  • Capsule Primary Container Content Quantity: 500.000
  • Active Medicament Medicinal Strength: 150.000 MILLIGRAMS DISOPYRAMIDE PHOSPHATE EQUIVALENT
Identification
  • NSN: 6505-01-275-7369
  • NIIN: 012757369
  • FSC: 6505 — Drugs and Biologicals
  • FSG: 65 — Medical, Dental, and Veterinary Equipment
General Description

The Disopyramide Phosphate Extended-, cataloged under National Stock Number 6505-01-275-7369, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. Government technical data includes 5 specifications, cited from the U.S. Government catalog. 3 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: BT.

Technical Specifications
ParameterValue
NSN6505-01-275-7369
Item NameDisopyramide Phosphate Extended-
FSC / FSG6505 / 65 — Drugs and Biologicals
StatusACTIVE
Long Action MethodEXTENDED RELEASE
Medical Designation and GradeUNITED STATES PHARMACOPEIA
Primary Container TypeBOTTLE
Capsule Primary Container Content Quantity500.000
Active Medicament Medicinal Strength150.000 MILLIGRAMS DISOPYRAMIDE PHOSPHATE EQUIVALENT
Lifecycle & Compliance
Acquisition StatusACTIVE
DEMIL CodeDEMIL A — No Demilitarization Required
HazardPossible hazard — SDS may be required (DLA HMIC P)
Criticality CodeX
Unit of IssueBT
Cross-Reference Index
No manufacturer part numbers on file in the U.S. Government catalog.
Reference documents
ReferenceMeaning
NORPACE CR 5/9 Secondary reference
Searle G D and Co
NDC00025-2742-51 3/9 Design control — primary reference
Pharmacia & Upjohn Inc
NDC00025-2742-51 5/9 Secondary reference
Searle G D and Co

Frequently Asked Questions

What is NSN 6505-01-275-7369?

NSN 6505-01-275-7369 is a Disopyramide Phosphate Extended-, classified under FSC 6505, Drugs and Biologicals. Status: active.

What are the specifications of 6505-01-275-7369?

Key specifications for 6505-01-275-7369: Long Action Method: EXTENDED RELEASE; Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Primary Container Type: BOTTLE; Capsule Primary Container Content Quantity: 500.000. 5 specifications are documented in the U.S. Government catalog.

Is NSN 6505-01-275-7369 hazardous material?

Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.

Sources

U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.

U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.

✓ Data cited from the U.S. Government catalog; commercial cross-references from OEM and certified industry sources.
PartsTable Design LLC · partstable.com